SCHEMBL8668773

SCHEMBL8668773

Oc1ccc([CH]Cc2ccc(O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABAT P80404 2/20 0.50
ALDH5A1 P51649 1/20 0.50
ESR1 P03372 4/20 0.48
ESR2 Q92731 3/20 0.48
ALDH1A1 P00352 3/20 0.42
CA2 P00918 3/20 0.42
MAPT P10636 2/20 0.42
APP P05067 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
SLC6A2 P23975 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTR3A P46098 1/20 0.41
BACE1 P56817 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IDO1 P14902 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2564898 0.89 NPC1 (0.46) ABATALDH5A1ESR1ESR2MAPT
SCHEMBL2528043 0.89 TAAR1 (0.50) ABATALDH5A1ALDH1A1CA2MAPT
SCHEMBL4348469 0.89 ESR1 (0.45) ABATALDH5A1ESR1ESR2CA2
SCHEMBL8749818 0.84 CALM1 (0.58) ESR2ALDH1A1MAPTAPPKDM4E
SCHEMBL7355796 0.81 ESR1 (0.56) ABATALDH5A1ESR1ESR2ALDH1A1
SCHEMBL8670278 0.80 PRSS1 (0.43) CA2CA12CA1CA4CA5A
SCHEMBL8552842 0.79 LCK (0.47) ABATALDH1A1CA2CA12CA1
SCHEMBL8669516 0.77 CYP2A6 (0.46) ABATALDH5A1ALDH1A1MAPTKDM4E
SCHEMBL7106133 0.76 APP (0.50) ESR1ESR2ALDH1A1CA2MAPT
SCHEMBL7106127 0.76 APP (0.50) ESR1ESR2ALDH1A1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026146-A Stable antimicrobial peptide 达纳-法伯癌症研究所股份有限公司 2018-05-11 CN disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed